Delivery Order SPE2DB22D1106-SPE2DB24FEXC5
- Not listed
- This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,477.36, is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a vaccine product. The award is placed against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,963.54, is a delivery order for the TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML vaccine product. The contract is a firm fixed-price arrangement with a performance period extending through May 7, 2025. This contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,817.70, is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML medical supplies. The contract is a firm fixed-price delivery order with a completion date of March 18, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,550.48 firm fixed-price delivery order is for the supply of the TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML vaccine product. The contract has a completion date of September 4, 2024 and was awarded on August 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,963.54, is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product used for healthcare purposes. The contract has a firm fixed price pricing type and a completion date of April 4, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. The award has a ceiling value of $2,349.60 and a period of performance through April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,856.75, is for the delivery of the TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML medical supply. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.75 delivery order contract is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product. The contract is a firm fixed-price delivery order with a completion date of November 29, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a federal...
- This is a $1,856.75 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product, to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,795.60, is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical vaccine product. The contract has a firm fixed price pricing type and is set to expire on March 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEXC5Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $167,107.50 firm-fixed-price contract, with a performance period through July 2024, is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a vaccine product. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the Department of Defense and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $167.1k | 6/14/24 |